Ascendis Pharma A/S (Nasdaq: ASND) today announced new data from Week 214 of its Phase 2 PaTH Forward Trial showing that long ...

Novo Nordisk presents positive results from phase 3 REAL8 basket study of once-weekly Sogroya at the joint Congress of ESPE and ESE: Bagsværd, Denmark Tuesday, May 13, 2025, 10:0 ...

The research is being presented at the Joint Congress of ESPE and ESE in Copenhagen Denmark, 10-13 May 2025. Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases ...

The Danish multinational said that Sogroya improved the yearly growth rate in pre-pubertal children born small for ...

Men with fertility issues have lower levels of phosphate in the blood than average, according to research presented at the ...

The European Society of Endocrinology (ESE), the European Society for Paediatric Endocrinology (ESPE) and the Danish endocrine community will host a high-level event titled: “Minimising the ...

The full range of Ascendis Pharma events and updates at ESPE & ESE 2025 include the following: ...

Taking place on 14 May 2025, in Copenhagen and online, the event will bring together leading European scientists, policymakers and civil society to address the urgent health and environmental threat ...

I am a Psychiatric Mental-Health Nurse Practitioner (PMHNP-BC) who provides psychiatric assessment and medication management. I see patients across the lifespan, children through adults.